| Literature DB >> 34986360 |
George M Bou-Assaf1, Ivan L Budyak2, Michael Brenowitz3, Eric S Day4, David Hayes5, John Hill6, Ranajoy Majumdar2, Paola Ringhieri7, Peter Schuck8, Jasper C Lin9.
Abstract
Analytical ultracentrifugation (AUC) is a critical analytical tool supporting the development and manufacture of protein therapeutics. AUC is routinely used as an assay orthogonal to size exclusion chromatography for aggregate quantitation. This article distills the experimental and analysis procedures used by the authors for sedimentation velocity AUC into a series of best-practices considerations. The goal of this distillation is to help harmonize aggregate quantitation approaches across the biopharmaceutical industry. We review key considerations for sample and instrument suitability, experimental design, and data analysis best practices and conversely, highlight potential pitfalls to accurate aggregate analysis. Our goal is to provide experienced users benchmarks against which they can standardize their analyses and to provide guidance for new AUC analysts that will aid them to become proficient in this fundamental technique.Entities:
Keywords: Analytical ultracentrifugation; Antibody drug(s); Antibody(s); Biopharmaceutical characterization; HPLC (high performance/pressure liquid chromatography; Monoclonal antibody(s); Protein aggregation
Mesh:
Substances:
Year: 2022 PMID: 34986360 PMCID: PMC9232890 DOI: 10.1016/j.xphs.2021.12.023
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.784